Floatz logo

Rivaroxaban

Atrial Appendage

Assistance Publique - Hôpitaux de ParisSmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Atrial Appendage cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
University Hospital, Bordeaux
Phase 4BB
Plavix
University Hospital, Bordeaux
Phase 4BB

Same molecule, other indications

Rivaroxaban is also rated in:

atrial fibrillationDormant
BBB
Indicative ·
79 / 100
View asset →
hemorrhagic diseaseDormant
BBB
Indicative ·
76 / 100
View asset →
thrombotic diseaseDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →